A liquid biopsy open database will be created as part of the Eli Lilly project, led by US Vice President Joe Biden. Some 20 stakeholders, including major biopharmaceutical firms and academic institutions, have committed to the Blood Profiling Atlas Pilot. It is hoped the project will lead to the development of blood profiling diagnostic technology for cancer. As part of the scheme, participants such as AstraZeneca, Cancer Moonshot and Pfizer will contribute raw data from different studies for further analysis.
A liquid biopsy open database will be created as part of the Cancer Moonshot project, led by US Vice President Joe Biden. Some 20 stakeholders, including major biopharmaceutical firms and academic institutions, have committed to the Blood Profiling Atlas Pilot. It is hoped the project will lead to the development of blood profiling diagnostic technology for cancer. As part of the scheme, participants such as AstraZeneca, Eli Lilly and Pfizer will contribute raw data from different studies for further analysis.